This discovery provides a biological explanation for how presence of the UNC13A risk SNPs in ALS-FTD patients with TDP-43 pathology modifies disease outcomes, negatively affecting survival from symptom onset [32, 33, 41–47]. The gene discussed is UNC13A; the disease is amyotrophic lateral sclerosis.